Mylène Sebagh
Mylène Sebagh is an expert in Hepatology at Assistance Publique - Hôpitaux de Paris (France). Mylène Sebagh has authored 203 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 500 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Transplantation - Surgery - Gastroenterology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2026
Number : 203
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Organ transudation dictates in vivo adhesion to tissues. PMID 41855852 — tissue adhesions, biocompatible materials, adhesives, tissues | Biomaterials | 2026 | 0 |
| Glycocalyx kinetics and injury during liver procurement and transplantation as predictors of early graft dysfunction. PMID 41377853 — glycocalyx, predictive value of tests, liver, reperfusion, reperfusion injury, transplants, angiopoietins, allografts, transplantation, plasma | Front Transplant | 2025 | 0 |
| Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. PMID 41060640 — pancreatic neoplasms, neoplasms, therapeutics, pancreatectomy | JAMA Surg | 2025 | 0 |
| Analysis of the Mitochondrial Dynamics in NAFLD: Drp1 as a Marker of Inflammation and Fibrosis. PMID 40806508 — liver diseases, fibrosis, non-alcoholic fatty liver disease, disease progression, mitochondrial dynamics, liver, alcoholics, mitophagy | Int J Mol Sci | 2025 | 0 |
| Underdiagnosis of Alpha-1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study. PMID 40448303 — liver transplantation, alpha 1-antitrypsin deficiency, retrospective studies, liver, pharmacology, diagnosis, transplants, therapeutics, alpha 1-antitrypsin | Aliment Pharmacol Ther | 2025 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map